ClinicalTrials.Veeva

Menu
C

Core Healthcare Group | Cerritos, CA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Elagolix
LY573144
Lasmiditan
CNTX-4975-05
Estradiol
Daridorexant
Norethindrone Acetate
Vibegron
ACT-541468
5-FU

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 25 total trials

A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine (PIONEER-PEDS2)

The reason for this 12-month, open-label study is to see if the study drug lasmiditan is safe and effective for the intermittent acute treatment of m...

Enrolling
Migraine
Drug: Lasmiditan

The reason for this study is to see if lasmiditan is safe and effective in children aged 6 to 17 with migraine. The study will last up to 20 weeks an...

Enrolling
Migraine
Drug: Placebo
Drug: Lasmiditan

The purpose of this study is to is to evaluate the efficacy and safety of retatrutide in participants with type 2 diabetes in participants who have o...

Enrolling
Overweight
Obesity
Drug: Placebo
Drug: Retatrutide

This is a Phase 3 Randomized Double-Blind Placebo-Controlled 6-month Parallel-Arm Study to Compare a Fixed Dose Combination of AD109 to Placebo in Ob...

Enrolling
OSA
Drug: Placebo
Drug: AD109

The purpose of this study is to measure the change in pain and function with subcutaneous injections of pentosan polysulfate sodium (PPS) compared wi...

Active, not recruiting
Osteoarthritis, Knee
Drug: Pentosan Polysulfate Sodium once weekly
Drug: Pentosan Polysulfate Sodium Fixed Dose

Trial sponsors

AbbVie logo
Lilly logo
Pfizer logo
C
Idorsia Pharmaceuticals logo
Sol-Gel Technologies logo
U
A
Amgen logo
Apnimed logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems